2025
The association between clinical trial participation, drug costs, and performance in the Oncology Care Model
Canavan M, Westvold S, Csik V, Franks J, Rocque G, Gross C, Adelson K. The association between clinical trial participation, drug costs, and performance in the Oncology Care Model. Journal Of The National Cancer Institute 2025, djaf008. PMID: 39842859, DOI: 10.1093/jnci/djaf008.Peer-Reviewed Original ResearchThis study investigates how clinical trial participation in the Oncology Care Model affects drug costs and performance, showing potential advantages for academic centers in value-based programs.
2024
Evaluation of completeness of commonly used data elements for clinical trial eligibility criteria using a registry-enhanced data collection process: Results from patients with non-small cell lung cancer (NSCLC) and colorectal cancer (CRC) at three community oncology practices.
Campbell Fontaine A, McAneny B, Tucker V, Koontz M, Trotter C, Paulson J, McMurdie P, Tezcan A, Peguero J, Peguero J, Campos L. Evaluation of completeness of commonly used data elements for clinical trial eligibility criteria using a registry-enhanced data collection process: Results from patients with non-small cell lung cancer (NSCLC) and colorectal cancer (CRC) at three community oncology practices. Journal Of Clinical Oncology 2024, 20: 346-346. DOI: 10.1200/op.2024.20.10_suppl.346.Peer-Reviewed Original ResearchNon-small cell lung cancerCommunity oncology practicesColorectal cancerDiagnosis dateOncology practiceCancer diagnosisData elementsEligibility assessmentColorectal cancer patientsCompletion ratesGenomic test resultsEssential data elementsLung cancerClinical trialsRemote staffMale to female ratioSystemic anti-cancer treatmentTrial eligibility criteriaPatient identificationECOG performance statusICD10 codesPatient RegistryYears of ageLung cancer diagnosisCell lung cancerFramework for Considering Primary and Subspecialty Palliative Care and Guiding Serious Illness Communication for Patients With Breast Cancer.
Dow L, Kapo J, Boyle F, Shin J. Framework for Considering Primary and Subspecialty Palliative Care and Guiding Serious Illness Communication for Patients With Breast Cancer. American Society Of Clinical Oncology Educational Book 2024, 44: e432554. PMID: 39018514, DOI: 10.1200/edbk_432554.Peer-Reviewed Original ResearchConceptsSubspecialty palliative carePalliative careCore components of palliative carePrimary palliative care skillsComponents of palliative careBreast cancerPalliative care skillsPrimary palliative carePalliative care specialistsType of careQuality of life of patientsCare of patientsResource-constrained settingsIllness communicationCare skillsCoordinated careIllness trajectoryLife of patientsOncology cliniciansCare specialistsManaging painOncology teamPhysical symptomsOncology practiceCareDevelopment and preliminary validation of a platform for systematic, unbiased pre-screening of non-small cell lung cancer (NSCLC) across three community oncology practices.
Campbell Fontaine A, McAneny B, Tucker V, Koontz M, Trotter C, Paulson J, Svedman C, Pan A, Peguero J, Campos L. Development and preliminary validation of a platform for systematic, unbiased pre-screening of non-small cell lung cancer (NSCLC) across three community oncology practices. Journal Of Clinical Oncology 2024, 42: e23230-e23230. DOI: 10.1200/jco.2024.42.16_suppl.e23230.Peer-Reviewed Original ResearchNon-small cell lung cancerClinical trialsCommunity oncology practicesMedical oncologistsNon-small cell lung cancer ptsOncology practiceCell lung cancerClinical trial patient populationTrial patient populationTesting ratesPre-screening of patientsIdentification of eligible patientsAssessment of eligibilityECOG PSClinical trial sitesMetastatic statusEligible patientsLung cancerRoutine clinical workflowPatient populationOncology patientsPatientsOncologist assessmentGold standardTreatment historyIntegrating 4 methods to evaluate physical function in patients with cancer (In4M): protocol for a prospective cohort study
Thanarajasingam G, Kluetz P, Bhatnagar V, Brown A, Cathcart-Rake E, Diamond M, Faust L, Fiero M, Huntington S, Jeffery M, Jones L, Noble B, Paludo J, Powers B, Ross J, Ritchie J, Ruddy K, Schellhorn S, Tarver M, Dueck A, Gross C. Integrating 4 methods to evaluate physical function in patients with cancer (In4M): protocol for a prospective cohort study. BMJ Open 2024, 14: e074030. PMID: 38199641, PMCID: PMC10806877, DOI: 10.1136/bmjopen-2023-074030.Peer-Reviewed Original ResearchConceptsPhysical function assessmentPhysical functionFunctional assessmentEvaluation of physical functionElectronic health record dataEvaluate physical functionHealth record dataSpanish-speaking patientsDigital health technologiesBreast cancerProspective cohort studyClinician-reported outcomesCancer clinical trialsClinical decision-makingStudy questionnairePatient-centred evaluationHealth technologiesMeasure symptomsOncology practiceCohort studyRecord dataPatient's impressionMayo ClinicEnglish-speakingWearable sensors
2023
Defining Priorities in Value-Based Cancer Care: Insights From the Alliance for Clinical Trials in Oncology National Cooperative Group Survey
Allen C, Snyder R, Horn D, Hudson M, Barber A, Smieliauskas F, Spears P, Edge S, Greenup R. Defining Priorities in Value-Based Cancer Care: Insights From the Alliance for Clinical Trials in Oncology National Cooperative Group Survey. JCO Oncology Practice 2023, 19: 932-938. PMID: 37651652, PMCID: PMC10615548, DOI: 10.1200/op.23.00159.Peer-Reviewed Original ResearchConceptsPatient-reported outcomesInclusion of PROsQuality of lifePatients' QOLClinical trialsHealth care systemHealth system performanceCancer CenterCancer-related health care costsCare systemTherapeutic assessmentAcademic cancer centerEvidence-based careCancer clinical trialsDirect patient careHealth care costsNational Cancer InstituteOncologic outcomesOverall survivalMedical oncologistsCancer careOncology practiceCancer InstituteNonphysician providersCare costsRekindling Joy in Medicine Through Thoughtful Communication: A Practical Guide.
Sanft T, Winer E. Rekindling Joy in Medicine Through Thoughtful Communication: A Practical Guide. American Society Of Clinical Oncology Educational Book 2023, 43: e100034. PMID: 37267275, DOI: 10.1200/edbk_100034.Peer-Reviewed Original ResearchThe association between systemic anticancer therapy (SACT) at the end of life (EOL) and acute care use among patients treated at oncology practices participating in the Oncology Care Model (OCM).
Canavan M, Sheth K, Scott J, Westvold S, Adelson K. The association between systemic anticancer therapy (SACT) at the end of life (EOL) and acute care use among patients treated at oncology practices participating in the Oncology Care Model (OCM). Journal Of Clinical Oncology 2023, 41: 6580-6580. DOI: 10.1200/jco.2023.41.16_suppl.6580.Peer-Reviewed Original ResearchSystemic anticancer therapyDay of deathOncology Care ModelEnd of lifeAcute care useIntensive care unitInpatient admissionsED visitsCare useReceipt of chemotherapyAcute care utilizationEmergency department useProportion of decedentsRates of chemotherapyChi-square testICU stayIO therapyCare unitCare utilizationInpatient stayCT patientsDepartment useHospice useCare metricsOncology practiceThe impact of receipt of systemic anticancer therapy (SACT) near the end of life (EOL) on cost among oncology practices participating in CMS' Oncology Care Model (OCM).
Adelson K, Canavan M, Sheth K, Scott J, Westvold S. The impact of receipt of systemic anticancer therapy (SACT) near the end of life (EOL) on cost among oncology practices participating in CMS' Oncology Care Model (OCM). Journal Of Clinical Oncology 2023, 41: e18923-e18923. DOI: 10.1200/jco.2023.41.16_suppl.e18923.Peer-Reviewed Original ResearchSystemic anticancer therapyDay of deathOncology Care ModelEnd of lifeAcute care useSystemic therapyCT patientsCare useImpact of receiptMean episode costReceipt of chemotherapyReceipt of immunotherapyICU useED costsIO patientsPharmacy costsOncology practiceEpisode costsTreatment decisionsDownstream careCare modelAmbulatory settingPart BPatientsImmunotherapyMitigating long-term and delayed adverse events associated with cancer treatment: implications for survivorship
Lustberg M, Kuderer N, Desai A, Bergerot C, Lyman G. Mitigating long-term and delayed adverse events associated with cancer treatment: implications for survivorship. Nature Reviews Clinical Oncology 2023, 20: 527-542. PMID: 37231127, PMCID: PMC10211308, DOI: 10.1038/s41571-023-00776-9.Peer-Reviewed Original ResearchConceptsAdverse eventsEvidence-based clinical practice guidelinesChemotherapy-associated adverse eventsNon-pharmacological treatment strategiesAdverse effectsClinical practice guidelinesAdverse treatment effectsCourse of therapyTotality of evidenceQuality of lifeTerms of survivalRisk assessment toolOptimal therapyCancer survivorsRisk factorsOncology practiceTreatment strategiesPractice guidelinesUnderlying biological mechanismsAppropriate managementAnticancer treatmentCancer treatmentEffective interventionsTreatment effectsChemotherapy
2022
Sexual and gender minority cultural humility training for oncology settings: An example of iterative adaptation and implementation
Kamen C, Reichelt M, Dadgostar P, Alpert A, Doucette C, Vaughan P, Keuroghlian A, Yousefi-Nooraie R. Sexual and gender minority cultural humility training for oncology settings: An example of iterative adaptation and implementation. Frontiers In Health Services 2022, 2: 958274. PMID: 36925900, PMCID: PMC10012625, DOI: 10.3389/frhs.2022.958274.Peer-Reviewed Original ResearchCultural humility trainingOncology practiceOncology settingOncology care settingsCancer care providersMultiple national organizationsThe Fenway InstituteImplementing such trainingInstitutional culture changeOncology providersTraining team membersReporting AdaptationsCare providersCare settingsHealth needsSGM patientsTraining interventionHealth carePractice environmentTraining sessionsOncology departmentContent of trainingTeam membersNational organizationsRadiation oncology departmentsCommunication About Fall Risk in Community Oncology Practice: The Role of Geriatric Assessment
Jensen-Battaglia M, Lei L, Xu H, Loh K, Wells M, Tylock R, Ramsdale E, Kleckner A, Mustian K, Dunne R, Kehoe L, Bearden J, Burnette B, Whitehead M, Mohile S, Wildes T. Communication About Fall Risk in Community Oncology Practice: The Role of Geriatric Assessment. JCO Oncology Practice 2022, 18: e1630-e1640. PMID: 35984998, PMCID: PMC9835996, DOI: 10.1200/op.22.00173.Peer-Reviewed Original ResearchConceptsHistory of fallsImpaired physical performanceCommunity oncology practicesGeriatric assessmentOncology practicePractice sitesPhysical performanceAudio-recordedOdds ratioCluster Randomized Controlled TrialUsual care armGA domain impairmentSource of morbidityFall riskCare armIntervention armGA summaryOlder adultsOncologists' knowledgeLinear mixed modelsGeneralized linear mixed modelsSecondary analysisSolid tumorsTreatment intentDomain impairmentSocial determinants of health in a prospective study of whole-exome sequencing in advanced cancer patients from underserved communities.
Patel K, Jun T, Chhadwa S, Zabala V, Gill S, Branchcomb R, Naidu S, Nathwani N, Hansen G, Hubbert A, Mukhi H, Mehta D, Nixon S, Kodali A, Zimmerman M, Hantash F, Oh W. Social determinants of health in a prospective study of whole-exome sequencing in advanced cancer patients from underserved communities. Journal Of Clinical Oncology 2022, 40: e18539-e18539. DOI: 10.1200/jco.2022.40.16_suppl.e18539.Peer-Reviewed Original ResearchSocial determinants of healthHousehold income <Advanced cancer patientsDeterminants of healthUnderserved communitiesCommunity oncology practicesSocial determinantsSocial determinants of health assessmentsSocial determinants of health characteristicsSocial determinants of health factorsSocial determinants of health dataOncology practiceFood insecurityHereditary cancer testingCancer patientsLower household incomeObservational studyHigher educational attainmentDiverse cohort of patientsOncology careProspective studyEnrollment questionnaireHispanic ethnicityCancer testingGenomic testingProtocol paper: Multi-site, cluster-randomized clinical trial for optimizing functional outcomes of older cancer survivors after chemotherapy
Yilmaz S, Janelsins M, Flannery M, Culakova E, Wells M, Lin P, Loh K, Epstein R, Kamen C, Kleckner A, Norton S, Plumb S, Alberti S, Doyle K, Porto M, Weber M, Dukelow N, Magnuson A, Kehoe L, Nightingale G, Jensen-Battaglia M, Mustian K, Mohile S. Protocol paper: Multi-site, cluster-randomized clinical trial for optimizing functional outcomes of older cancer survivors after chemotherapy. Journal Of Geriatric Oncology 2022, 13: 892-903. PMID: 35292232, PMCID: PMC9283231, DOI: 10.1016/j.jgo.2022.03.001.Peer-Reviewed Original ResearchConceptsNational Cancer Institute Community Oncology Research ProgramPatient-reported physical functionOlder cancer survivorsCancer survivorsPrimary care physiciansPatient-reported cognitive functionCommunity oncology practicesPhysical functionUniversity of Rochester Cancer CenterCaregiver qualityGeriatric evaluationCaregivers' quality of lifeCluster randomized clinical trialOncology practiceSurvivorship care interventionsWeeks of study enrollmentHealth care aimOncology Research ProgramCognitive functionFunctional outcomesCluster randomized trialQuality of lifeCaregiver burdenCaregiver distressUsual care
2021
Impact of the COVID-19 Pandemic on Treatment Patterns for Patients With Metastatic Solid Cancer in the United States
Parikh RB, Takvorian SU, Vader D, Wileyto E, Clark AS, Lee DJ, Goyal G, Rocque GB, Dotan E, Geynisman DM, Phull P, Spiess PE, Kim RY, Davidoff AJ, Gross CP, Neparidze N, Miksad RA, Calip GS, Hearn CM, Ferrell W, Shulman LN, Mamtani R, Hubbard RA, Investigators T. Impact of the COVID-19 Pandemic on Treatment Patterns for Patients With Metastatic Solid Cancer in the United States. Journal Of The National Cancer Institute 2021, 114: 571-578. PMID: 34893865, PMCID: PMC9002283, DOI: 10.1093/jnci/djab225.Peer-Reviewed Original ResearchConceptsMetastatic solid cancersFirst-line systemic therapyTreatment initiationSolid cancersSystemic therapyTreatment patternsMyelosuppressive therapyTreatment selectionCommunity-based oncology practicesCOVID-19 pandemicTechnology-enabled abstractionDays of diagnosisLife-threatening conditionInterrupted time series analysisMetastatic diagnosisUS patientsEffect modificationOncology practiceMetastatic cancerAdjusted probabilityPatientsPandemic periodPandemic-related delaysTherapyCancerSIOG2021-0097* The impact of Geriatric Assessment on discussion of falls in community oncology practice: A secondary analysis of a nationwide cluster randomized trial
Jensen-Battaglia M, Lei L, Xu H, Loh K, Wells M, Tylock R, Ramsdale E, Kleckner A, Mustian K, Dunne R, Giguere J, Bearden J, Burnette B, Whitehead M, Mohile S, Wildes T. SIOG2021-0097* The impact of Geriatric Assessment on discussion of falls in community oncology practice: A secondary analysis of a nationwide cluster randomized trial. Journal Of Geriatric Oncology 2021, 12: s36. DOI: 10.1016/s1879-4068(21)00396-9.Peer-Reviewed Original ResearchDigital Health for Optimal Supportive Care in Oncology: Benefits, Limits, and Future Perspectives
Aapro M, Bossi P, Dasari A, Fallowfield L, Gascón P, Geller M, Jordan K, Kim J, Martin K, Porzig S. Digital Health for Optimal Supportive Care in Oncology: Benefits, Limits, and Future Perspectives. Kompass Nutrition & Dietetics 2021, 1: 72-90. DOI: 10.1159/000519151.Peer-Reviewed Original ResearchSupportive careDigital health solutionsHealth solutionsHealth economic endpointsOncology supportive careRoutine supportive careHealthcare resource utilizationOptimal supportive careImprovement of QOLTreatment of symptomsPatient-centered careEvidence-based therapeutic interventionsDifferent healthcare systemsUnplanned hospitalizationMost patientsSymptom supportOncology practiceSymptom distressClinical studiesPatient managementOral drugsSymptom monitoringPatient complianceTreatment efficacyTherapeutic interventionsUsing Geriatric Assessment to Guide Conversations Regarding Comorbidities Among Older Patients With Advanced Cancer
Kleckner A, Wells M, Kehoe L, Gilmore N, Xu H, Magnuson A, Dunne R, Jensen-Battaglia M, Mohamed M, O'Rourke M, Vogelzang N, Dib E, Peppone L, Mohile S. Using Geriatric Assessment to Guide Conversations Regarding Comorbidities Among Older Patients With Advanced Cancer. JCO Oncology Practice 2021, 18: e9-e19. PMID: 34228510, PMCID: PMC8758128, DOI: 10.1200/op.21.00196.Peer-Reviewed Original ResearchConceptsIntervention armAdvanced cancerCluster randomized trialOlder patientsTreatment planningComorbidity QuestionnaireUsual carePractice sitesGA summaryClinical encountersLinear mixed modelsSecondary analysisOncology practiceGA domainsEligible patientsInterventionGuided conversationsComorbiditiesOncologistsTreatment outcomesMixed modelsPatientsComorbid concernsCancerRandom effectsBundling cancer subtypes in value-based care: A pilot analysis of lymphoma episodes in the Oncology Care Model.
Yue A, Chaudhry B, Schleicher S, Huntington S, Lyss A, Connor N, Tran L, Adelson K. Bundling cancer subtypes in value-based care: A pilot analysis of lymphoma episodes in the Oncology Care Model. Journal Of Clinical Oncology 2021, 39: e18850-e18850. DOI: 10.1200/jco.2021.39.15_suppl.e18850.Peer-Reviewed Original ResearchCommunity oncology practicesAcademic medical centerOncology Care ModelEpisode costsWaldenstrom's macroglobulinemiaCare modelCancer subtypesLarge community oncology practiceProportion of subtypesLarge academic medical centerICD-10 diagnosisIntensity of careValue-based careCohort studyClinical featuresCommon subtypeFrequent subtypeOncology practiceLymphoma populationLymphoma subtypesMedical CenterHeterogeneous diseaseInappropriate shiftIndividual subtypesSubtypesAssessing the immediate impact of COVID‐19 on surgical oncology practice: Experience from an NCI‐designated Comprehensive Cancer Center in the Northeastern United States
Gazivoda V, Greenbaum A, Roshal J, Lee J, Reddy L, Rehman S, Kangas‐Dick A, Gregory S, Kowzun M, Stephenson R, Laird A, Alexander H, Berger A. Assessing the immediate impact of COVID‐19 on surgical oncology practice: Experience from an NCI‐designated Comprehensive Cancer Center in the Northeastern United States. Journal Of Surgical Oncology 2021, 124: 7-15. PMID: 33765341, PMCID: PMC8250700, DOI: 10.1002/jso.26475.Peer-Reviewed Original ResearchConceptsSurgical oncology practiceNew patient visitsOncology practiceCancer CenterPatient visitsOncology subspecialtyNCI-designated Comprehensive Cancer CenterAddition of telehealthCoronavirus disease 2019 (COVID-19) pandemicComprehensive cancer centerCancer patient careCOVID-19Disease 2019 pandemicClinic visitsPrimary outcomeTelehealth visitsRetrospective studyGynecologic oncologyOperative volumeGastrointestinal oncologyPractice volumeNumber of casesPatient careStudy periodVisits
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply